Proteomic Profiling in Early Venous Stenosis Formation in a Porcine Model of Hemodialysis Graft

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 2, 2009, Pages 241-251

  Misra, Sanjay ^a   Fu, Alex A ^a   Puggioni, Alessandra ^a   Glockner, James F ^a   McKusick, Michael A ^a   Bjarnason, Haraldur ^a   Mukhopadhyay, Debabrata ^b  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CREATININE; DECORIN; FETUIN A; LACTOFERRIN; MACROPHAGE MIGRATION INHIBITION FACTOR; POLITEF; PYRUVATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOWN REGULATION; GRAFT FAILURE; HEMODIALYSIS; KIDNEY ARTERY EMBOLIZATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; STENOSIS; SWINE; UPREGULATION; UREA NITROGEN BLOOD LEVEL; VEIN GRAFT;

ANIMALS; BLOOD VESSEL PROSTHESIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PROTEOME; RENAL DIALYSIS; SWINE; VENOUS INSUFFICIENCY;

EID: 58249140377     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2008.10.004     Document Type: Article

References (43)

1. Collins A.J., Kasiske B., Herzog C., et al. Excerpts from the united states renal data system 2003 annual data report: atlas of end-stage renal disease in the united states. Am J Kidney Dis 42 6 suppl 5 (2003) A5-A7
2. Schwab S.J., Harrington J.T., Singh A., et al. Vascular access for hemodialysis. Kidney Int 55 (1999) 2078-2090
3. Rekhter M., Nicholls S., Ferguson M., and Gordon D. Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb 13 (1993) 609-617
4. Misra S., Fu A., Pugionni A., et al. Expression of hypoxia inducible factor-1a in a porcine model of chronic renal insufficiency with arteriovenous polytetrafluoroethylene grafts. J Vasc Interv Radiol 19 (2008) 260-265
5. Misra S., Fu A., Rajan D., et al. Increased expression of hif-1 alpha, MIF, pro MMP-2, pro MMP-9, and TIMP-1 in hemodialysis grafts. J Vasc Interv Radiol 19 (2008) 252-259
6. Misra S., Doherty M.G., Woodrum D., et al. Adventitial remodeling with increased matrix metalloproteinase-2 activity in a porcine arteriovenous polytetrafluoroethylene grafts. Kidney Int 68 (2005) 2890-2900
7. Weiss M.F., Scivittaro V., and Anderson J.M. Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis 37 (2001) 970-980
8. Roy-Chaudhury P., Kelly B.S., Miller M.A., et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 59 (2001) 2325-2334
9. Rotmans J.I., Velema E., Verhagen H.J., et al. Matrix metalloproteinase inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model. J Vasc Surg 39 (2004) 432-439
10. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., and Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17 (1999) 994-999
11. Misra S., Lee N., Fu A., et al. Increased expression of a disintegrin and metalloproteinase thrombospondin-1 (ADAMTS-1) in thrombosed hemodialysis grafts. J Vasc Interv Radiol 19 (2008) 111-119
12. Misra S., Gordon J.D., Fu A.A., et al. The porcine remnant kidney model of chronic renal insufficiency. J Surg Res 135 (2006) 370-379
13. Misra S., Fu A.A., Puggioni A., et al. Increased shear stress with up regulation of VEGF-a and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts. Am J Physiol Heart Circ Physiol 294 (2008) H2219-H2230
14. Parker K.C., Patterson D., Williamson B., et al. Depth of proteome issues: a yeast isotope-coded affinity tag reagent study. Mol Cell Proteomics 3 (2004) 625-659
15. Misra S., Woodrum D., Homburger J., et al. Assessment of wall shear stress changes in arteries and veins of arteriovenous polytetrafluoroethylene grafts using magnetic resonance imaging. Cardiovasc Intervent Radiol 29 (2006) 624-629
16. Abbott W.M., Megerman J., Hasson J.E., L'Italien G., and Warnock D.F. Effect of compliance mismatch on vascular graft patency. J Vasc Surg 5 (1987) 376-382
17. Pedersen K.O. Fetuin, a new globin isolated from serum. Nature 154 (1944) 575
18. Schultze H.E., Heide K., and Haupt H. Charakterisierung eines niedermolekularen 2-mukoids aus humanserum. Naturwiss 49 (1962) 15-17
19. Ketteler M., Bongartz P., Westenfeld R., et al. Association of low fetuin-a (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361 (2003) 827-833
20. Schafer C., Heiss A., Schwarz A., et al. The serum protein {alpha}2-heremans-schmid glycoprotein/fetuin-a is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112 (2003) 357-366
21. Szweras M., Liu D., Partridge E.A., et al. Alpha 2-hs glycoprotein/fetuin, a transforming growth factor-beta /bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem 277 (2002) 19991-19997
22. Tajirian T., Dennis J., and Swallow C. Regulation of human monocyte proMMP-9 production by fetuin, an endogenous TGF-b antagonist. J Cell Physiol 185 (2000) 174-183
23. Misra S., Fu A.A., Anderson J., et al. Fetuin-a expression in early venous stenosis formation in a porcine model of hemodialysis graft failure. J Vasc Interv Radiol 19 (2008) 1477-1482
24. Brock J.H. The physiology of lactoferrin. Biochem Cell Biol 80 (2002) 1-6
25. Ward P.P., Uribe-Luna S., and Conneely O.M. Lactoferrin and host defense. Biochem Cell Biol 80 (2002) 95-102
26. Heydarkhan-Hagvall S., Chien S., Nelander S., et al. DNA microarray study on gene expression profiles in co-cultured endothelial and smooth muscle cells in response to 4- and 24-h shear stress. Mol Cell Biochem 281 (2006) 1-15
27. Mader J.S., Smyth D., Marshall J., and Hoskin D.W. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells. Am J Pathol 169 (2006) 1753-1766
28. Morand E.F., Leech M., and Bernhagen J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis 5 (2006) 399-411
29. Chen Z., Sakuma M., Zago A.C., et al. Evidence for a role of macrophage migration inhibitory factor in vascular disease. Arterioscler Thromb Vasc Biol 24 (2004) 709-714
30. Burger-Kentischer A., Gobel H., Kleemann R., et al. Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF). Atherosclerosis 184 (2006) 28-38
31. Schober A., Bernhagen J., Thiele M., et al. Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein e-deficient mice. Circulation 109 (2004) 380-385
32. Border W.A., Noble N.A., Yamamoto T., et al. Natural inhibitor of transforming growth factor-[beta] protects against scarring in experimental kidney disease. Nature 360 (1992) 361-364
33. Giri S.N., Hyde D.M., Braun R.K., Gaarde W., Harper J.R., and Pierschbacher M.D. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol 54 (1997) 1205-1216
34. Yamaguchi Y., and Ruoslahti E. Expression of human proteoglycan in chinese hamster ovary cells inhibits cell proliferation. Nature 336 (1988) 244-246
35. Fischer J.W., Kinsella M.G., Clowes M.M., Lara S., Clowes A.W., and Wight T.N. Local expression of bovine decorin by cell-mediated gene transfer reduces neointimal formation after balloon injury in rats. Circ Res 86 (2000) 676-683
36. Jarvelainen H., Vernon R.B., Gooden M.D., et al. Overexpression of decorin by rat arterial smooth muscle cells enhances contraction of type I collagen in vitro. Arterioscler Thromb Vasc Biol 24 (2004) 67-72
37. Nelimarkka L., Salminen H., Kuopio T., et al. Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis. Am J Pathol 158 (2001) 345-353
38. Riessen R., Isner J.M., Blessing E., et al. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol 144 (1994) 962-974
39. Kim C.W., Son K.N., Choi S.Y., and Kim J. Human lactoferrin upregulates expression of kdr/flk-1 and stimulates VEGF-a-mediated endothelial cell proliferation and migration. FEBS Lett 580 (2006) 4332-4336
40. Bergstrand C.G., and Czar D. Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Invest 8 (1956) 174
41. Motoyama T., Watanabe H., Yamamoto T., and Sekiguchi M. Production of alpha-fetoprotein by human germ cell tumors in vivo and in vitro. Acta Pathol Jpn 37 (1987) 1263-1277
42. Kamei S., Kono K., Amemiya H., et al. Evaluation of VEGF and VEGF-c expression in gastric cancer cells producing alpha-fetoprotein. J Gastroenterol 38 (2003) 540-547
43. Dahl H.H. Pyruvate dehydrogenase-1 alpha deficiency: males and females differ yet again. Am J Hum Genet 56 (1995) 553-557